Global Gene Expression Analysis Market Significant Profits Estimated to be Generated by 2023

 Gene Expression Analysis Market Overview

As per Market Research Future (MRFR) analysis, the global gene expression analysis market is estimated to hold a market value of USD 3.250 million with a CAGR 9.1% from 2018 to 2023 (forecast period). 

Gene expression analysis is a research focused on functional genomics that broadens the scope of the study of genes and gene transcripts. Synthesizing functional gene products like functional RNAs and protein species provides insights into how an intact organism survives when a particular gene is missing. 

Get a FREE Sample with Complete TOC By Considering the COVID-19 impact on Global Market @ https://www.marketresearchfuture.com/sample_request/7805

Gene Expression Analysis Market Dynamics

Personalized medicine is becoming more popular, with an increasing number of genetic disorders. In addition, increasing awareness of personalized medicine is expected to drive growth over the forecast period. As per the data published by Foley & Lardner LLP, the Food and Drug Administration (FDA) approved 16 new personalized medicinal products in 2017. Moreover, the advancement of genomic databases increased government support for genomics, and growth in personalized medicine is likely to drive the market. 

However, the shortage of skilled labor and the high cost of instruments may inhibit market growth during the forecast period. 

Gene Expression Analysis Market Segmentation

The global market for gene expression analysis has been segmented into product, consumables, instruments, services, application, and end-user.

Based on the product, the global market for gene expression analysis has been segmented into consumables and instruments.

Based on consumables, the global market for gene expression analysis has been further segmented into reagents and DNA chips.

Based on instruments, the global market for gene expression analysis has been further segmented into next-generation sequencing (NGS), polymerase chain reaction (PCR), microarray, Sanger sequencing, and others.

Based on services, the global market for gene expression analysis segmented into gene expression profiling services, sequencing services, bioinformatics solutions, and others.

Based on the application, the global market for gene expression analysis has been segmented into drug discovery, diagnosis, research, and others.

Based on end-user, the global market for gene expression analysis has been segmented into academic & research institutes, pharmaceutical & biotechnology companies, contract research organizations, and others. 

Gene Expression Analysis Market Regional Analysis

Regionally, the global gene expression analysis market has been segmented into the Americas, Europe, Asia Pacific, and the Middle East & Africa.

The Americas are predicted to dominate the global market for gene expression analysis due to increasing research activities and the increasing popularity of gene expression tests. In addition, the well-developed healthcare sector is predicted to improve the American market for gene expression analysis.

Europe is predicted to hold the second-largest position in the global market for gene expression analysis. Market growth in this region is due to the availability of research funding.

The Asia Pacific is projected to be the fastest-growing region on the market due to rising investment by governments in genomics and continuously developing economies. As stated in the report published by the International Journal of Social and Developmental Concerns in October 2017, the growth of public primary and secondary care facilities in Malaysia has decreased over the last few years and has not kept pace with modern urbanization. These factors, therefore, restrict the growth of the market in this region. 

The Middle East and Africa are estimated to have the least market share. 

Gene Expression Analysis Market Key Players

Some of the significant participants in the global gene expression analysis market are GENERAL ELECTRIC COMPANY, Illumina, Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific, Pacific Biosciences of California, Inc., Oxford Gene Technology, BGI, PerkinElmer Inc., Agilent Technologies, Inc., QIAGEN, Eurofins Scientific, Genotypic Technology Pvt Ltd, Danaher, Macrogen Inc. 

Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/gene-expression-analysis-market-7805 

Leukemia Therapeutics Market to Witness an Outstanding Growth by 2023

 Leukemia Therapeutics Market Scenario:

The clinical condition an in which an increased number of abnormal leucocytes or generally called white blood cells of malignant characteristic is called leukemia. Frequent infections, fever with chills and fatigue are early signs of leukemia. Acute, chronic, lymphocytic, and myelogenous leukemias are classified under leukemia. Cancer statistics center of American Cancer Society estimates 61780 new cases of leukemia in 2019. Treatment for such a malicious disease requires intense therapeutic attention. Therefore, the need for accurate treatment in the rising population of leukemia patients is the major factor impelling the global leukemia therapeutics market growth. The traditional therapies involved in the treatment of leukemia are chemotherapy, biological therapy, targeted therapy, radiation therapy, and stem cell transplant. The complex pathology of leukemia demands advancements in medical infrastructure for treatment. Hence, letting the market key players immense opportunity to invest in research and development and bring forth innovation in the leukemia therapy. This generates a lead for clinical researchers to investigate better drug administration methods. Efforts which are being made to deliver more effective leukemia therapies is likely to trigger the leukemia therapeutics industry market growth.

However, on the flip side, the high cost of existing leukemia therapies and investment required for developing new therapies is curbing the expansion of leukemia therapeutics market.

Global leukemia therapeutics market is expected to grow significantly over the forecast period. It is anticipated that the market held the value of USD 10.7 billion in 2017 and is projected to grow at a CAGR of 5.3% during the assessment period predicts Market Research Future (MRFR).

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/7425

Segmentation

The global leukemia therapeutics market has been segmented into type, applications, and region.

Based on applications, leukemia therapeutics market is segmented into acute lymphocytic leukemia, acute myelogenous leukemia, chronic lymphocytic leukemia, chronic myelogenous leukemia, and others. The acute lymphocytic leukemia segment is expected to account for the largest share segment of the market in 2017.

Based on type, leukemia therapeutics market is segmented into chemotherapy, biological therapy, targeted therapy, radiation therapy, and stem cell transplant. The chemotherapy segment is expected to account for the largest share segment of the market in 2017. Chemotherapy segment further sub segmented into alkylating agents, antimetabolites, antitumor antibiotics, and others.

Top Key Players

• Eisai Co., Ltd (Japan)
• Novartis AG (Switzerland)
• Pfizer Inc. (US)
• GlaxoSmithKline plc (UK)
• Bristol-Myers Squibb Company (US)
• Hoffmann-La Roche AG (Switzerland)
• Sanofi S.A. (France)
• Teva Pharmaceutical Industries Ltd (Israel)
• Amgen Inc (US)
• Takeda Pharmaceutical Company Ltd (Japan)

Regional Market Summary

Geographically, the Americas is anticipated to dominate the global leukemia therapeutics market owing to a well-established player, innovative therapies to drive the market for leukemia, increase prevalence of leukemia, and increasing older population.

Europe is expected to hold the second largest position in the global leukemia therapeutics market. The market growth in this region is attributed to increase prevalence of leukemia.

The leukemia therapeutics market in Asia-Pacific region consists of countries namely China, Japan, Republic of Korea, India, Australia and Rest of Asia-Pacific. The Asia-Pacific region is expected to be fastest growing region.

The Middle East & Africa has the least share of the leukemia therapeutics market.

Browse More Report Details @ https://www.marketresearchfuture.com/reports/leukemia-therapeutics-market-7425

 

Plasma Fractionation Market Estimated to Witness a Vigorous Growth by 2023

 Plasma Fractionation Market Overview: 

The global plasma fractionation market is showing ample scope for growth and it is projected to secure a 6.5% CAGR during the forecast period of 2018 to 2023. Market Research Future (MRFR), in its attempt to understand the market proceedings, has revealed several factors that can impact the growth. The better technological influx and their easy integration in the mainstream, improvement in the infrastructure, and a rise in investment to boost the research works would help the global market achieve growth.  

However, the process is getting hindered in lesser-developed regions owing to which the market may find the growth a bit sluggish.  

Get a FREE Sample (Including COVID19 Impact Analysis, Full TOC, Tables and Figures) of Plasma Fractionation Market @ https://www.marketresearchfuture.com/sample_request/7397

Plasma Fractionation Market Segmentation: 

The global market for plasma fractionation has been segmented by market researchers on the basis of product, application, and end user. MRFR analysts help in a proper assessment of the market to assist players in increasing their profit margin.  

By product, the global market study on the plasma fractionation has been segmented into coagulation factor concentrates, protease inhibitors, albumin, immunoglobulin, and others. The immunoglobulin segment has been segmented further into subcutaneous immunoglobulin (SCIG), intravenous immunoglobulin (IVIG), and others. The coagulation factor concentrates segment encompasses Factor IX, Von Willebrand Factor, Factor VIII, Fibrinogen Concentrates, Prothrombin Complex Concentrate, and Factor XIII. 

By application, the global discussion on the plasma fractionation market includes neurology, hematology, immunology, hemato-oncology, pulmonology, rheumatology, critical care, and others. The immunology segment is getting significant traction to boost the treatment process against viral attacks.  

By end user, the global report on the plasma fractionation market includes clinical research laboratories, hospitals & clinics, academic institutes, and others. Various clinical research laboratories are impacting the global market as they are trying to develop new methods of treatments. The Academic institutes are also fetching revenues as they are getting bolstered by government and private funding.  

Plasma Fractionation Market Regional Analysis: 

The Americas would dominate the global Plasma Fractionation Market and it would be backed by the US. The infrastructural superiority, better inclusion of technology, and high rate of investment to support the process would ensure the market’s upward trajectory. Asia Pacific would register the fastest CAGR during the forecast period.  

Plasma Fractionation Market Competitive Landscape: 

The global market on the plasma fractionation is getting inspired by the contributions of companies by Biotest AG, China Biologic Products Holdings, Inc., Bio Products Laboratory (BPL), Grifols, S.A., Japan Blood Products Organization, CSL Limited, Green Cross Corporation, LFB group, Octapharma AG, Kedrion S.p.A, Shanghai RAAS, Shire, Sanquin, and others. These companies are trying to expand their portfolio through innovation, merger, acquisition, and joint venture. The process is witnessing a surge in funding for the research and development sector. This has led to the development of better marketing strategies, branding, and launching. MRFR recorded these moves to influence the study of the market and facilitate future strategy-making policies.  

Plasma Fractionation Industry News: 

In May 2020, Headspring, a company known for its leading presence in the strategy and development, announced a partnership with the Plasma Protein Therapeutics Association (PPTA). The attempt is to develop a state-of-the-art system and help in protecting and ensuring donor health and plasma safety. This will accelerate the production of life-saving plasma protein therapies (PPTs), which would be helpful in treating patients with rare, chronic diseases. PPTA is known for being collectors of source plasma used for fractionation. 

The global market for plasma fractionation is getting ample traction from the COVID-19 treatment demands. Plasma therapy is gaining ground to treat patients with the disease, which is boosting the market prospect of the plasma fractionation.  

Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/plasma-fractionation-market-7397

Global Biochips Market Expected to Grow with a healthy CAGR

 Global Biochips Market trends held a market value of USD 7,300 million in 2017, according to the MRFR. The market is expected to exhibit a strong 16.6% CAGR over the forecast period from 2018 to 2023, according to the report.

Biochips are intended to function in biological environment, preferably inside living organism. The factors such as increasing technological advancements in biochips is the major driving factor for the market. Moreover, increasing adoption of personalized medicine, as personalised medicine has many applications in cancer genomics. Furthermore, growing applications will boost the biochips market size and growth during forecast period. For instance, biochips can perform thousands of biological reactions operations in few seconds.  

However, high cost of the instruments and stringent regulatory guidelines may restrain the growth of the market.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/7063

According to national Cancer Institute, in 2018, an estimated 1,735,350 new cases of cancer were diagnosed in the United States and 609,640 people may die from the disease. 
Competitive Landscape:
Perkinelmer, Inc., Fluidigm Corporation, Agilent Technologies, Inc., Abbott Laboratories, Bio-Rad Laboratories Inc., Cepheid Inc., Illumina, Inc., GE Healthcare, Thermo Fisher Scientific, Inc, Roche Diagnostics are some of the prominent players in the global biochips market.

Segmentation:
The Global Biochips Market has been segmented into type, technology, and end user.

By type, the market has been segmented into DNA chips, lab-on-a-chip, protein chips, cell arrays, and tissue arrays. DNA chips is further segmented into gene expression, SNP genotyping, cancer diagnosis & treatment, genomics, drug discovery, agricultural biotechnology, and others. Lab-on-a-chip is further segmented into clinical diagnostics, genomics, IVD (In-Vitro Diagnostic) & POC (Point of care), Proteomics, Drug Discovery, and others. Protein chips is further segmented into proteomics, expression profiling, diagnostics, high-throughput screening, drug discovery, others.

Based on technology, the market has been segmented into microarrays and microfluidics.

The biochips market, by end user, has been segmented into biotechnology and pharmaceutical companies, hospitals and diagnostics centers, academic & research institutes, and others.

Regional Market Summary

Geographically, the Americas is anticipated to dominate the global biochips market owing to the high domestic income, and presence of major market players. Moreover, increasing patient population in US. According to American Cancer Society, the overall estimate of 1,735,350 cases for 2018 equals more than 4,700 new cancer diagnoses each day.

Europe is expected to hold the second largest position in the global biochips market. The market growth in this region is attributed to the presence of strong academic & research base and availability of funding for research in the European countries. For instance, the European Research Council (ERC) provides grants for technological and scientific research conducted within the European Union (EU).

The biochips market in Asia-Pacific region consists of countries namely China, Japan, Republic of Korea, India, Australia and Rest of Asia-Pacific. The Asia-Pacific region is expected to be fastest growing region owing to increasing government focus on biomedical and biotechnology sector and growing number of target population in the region.  

The Middle East & Africa has the lowest biochips market share in global market. Majority of the market of the region is anticipated to be held by the Middle East region owing to the growing government initiatives for the healthcare sector.  

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/biochips-market-7063

Surgical Drills Market Estimated to Witness a Vigorous Growth by 2023

 Surgical drills as the name itself suggests, are drill machines which are used during the various surgical procedures. Their main function is to drill, cut, and bore holes in the bone in order to attach surgical pins, plates, or screws. There are several types of surgical drills available which are powered by different source. These include pneumatic drills, electric drills, and battery powered drills among others. Surgical drills have simplified the tedious job of a surgeon and reduced the surgery time significantly. Surgical drills have become an important tool in the surgical procedures. Due to high surgical drills market demand and Increasing number of orthopedic and dental surgeries, high awareness about the dental hygiene and high disposable income are some of the factors contribute to the growth of the surgical drills market.

Key players:

Adeor medical AG, AlloTech Co.Ltd. Arthrex Inc., B.Braun Melsungen AG, CONMED Corporation, De Soutter Medical, DePuy Synthes, Medtronic plc, Stryker Corporation and Zimmer Biomet Holdings, Inc. are some of the key players in the global surgical drills market.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/7035

Segmentation:

The Global Surgical Drills Market has been segmented into product, application and end-user.Based on products, the market has been segmented into, pneumatic drills, electric drills, battery powered drills, accessories, and others. The pneumatic drills segment is expected to account for the largest share in the global surgical drills market in 2017. This large share is majorly attributed to the wider acceptance of the devices, and better patient compliance as compared to other products. Based on application, the market has been segmented into orthopedic surgery, neurosurgery, ENT, dental surgery, and other. The orthopedic surgery segment is expected to account for the largest share in the global surgical drills market in 2017 followed by dental surgery segment.Based on end-users, the market has been segmented into hospitals & clinics, ambulatory surgical centers, academic and research institutes, and others. The hospitals & clinics segment is expected to account for the largest share in the global surgical drills market in 2017. At the same time, the increasing establishments of the ambulatory surgical centers in the developed and developing countries has led this segment to grow at the fastest rate during the forecast period.

Based on the regions, the market for surgical drills is segmented in to, the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The surgical drills market in the Americas region has further been segmented into North America and South America, where-in the North American market is further divided into the US and Canada.European surgical drills market has been segmented into Western Europe and Eastern Europe where-in Western Europe region is further divided into Germany, France, the UK, Italy, Spain, and the rest of Western Europe.  The surgical drills market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The surgical drills market in the Middle East & Africa has been segmented into regions such as the Middle East and Africa.

Regional Market Summary

Geographically, the Americas is anticipated to dominate the global surgical drills market owing to the rising number of the orthopaedic surgeries, increasing awareness about dental hygiene leading to increase in dental procedures and surgeries. The development of the better surgical approaches and advanced treatment procedures have affected the growth of the American market in a positive way. Moreover, high awareness among American population, state of the art medical infrastructure, high disposable income, are some of the many factors that drive the growth of the surgical drills market in this region.

Europe is expected to hold the second largest market share in the global surgical drills market. The market growth in this region is majorly attributed to the increasing government support for the device manufacturers. Geographical expansion of companies has led to the wider reach of the medical products and services which has brought a huge change in terms of the acceptance and implementation of the new products as well as procedures. Similarly, Asia-Pacific region has observed a rapid growth in the surgical drills market owing to the development in the medical sector in developing countries like India and China. Moreover, increase in government funding for healthcare, rising R&D expenditure, and growing number of medical device companies in the region has led to its fastest growth during the forecast period. The Middle East & Africa region is anticipated to show minor growth opportunities in the surgical drills market during the forecast period.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/surgical-drills-market-7035

 

Global Animal Genetics Market Research Report 2020 Analysis and Forecast to 2023

 Animal Genetics Market Overview

According to the Market Research Future (MRFR) analysis, the global animal genetics market is estimated to register a CAGR of 8.4% from 2018 to 2023 (forecast period). The report offers an in-depth overview of the industry, including production, suppliers, quality, consumption, growth rate, profit margins, services, imports and exports, and technology advancements.

Animal genetics is a field of genetics that is dedicated to the study of genetic variability and inheritance, especially for domestic and wild animals. For commercial purposes, animal genetics is used for DNA typing, genetic disease testing, and genetic trait testing. This methodology uses a hybrid population, ontogenetic, and cytological studies to determine genetic hybridizations. For example, genetically modified cows may be able to produce more milk and may be less vulnerable to common cattle diseases, such as clostridial disease, bovine respiratory disease complex, etc., thereby increasing the overall income of cattle farmers. 

Get a FREE Sample with Complete TOC By Considering the COVID-19 impact on Global Market @ https://www.marketresearchfuture.com/sample_request/7004

Animal Genetics Market Dynamics  

The significant factor responsible for influencing this market is the increase in the consumption of animal-derived protein, the growth of the global population, and rapid urbanization. The increasing focus on the identification of superior breeds has contributed to the growth of the market for toxicology testing. 

However, factors such as the substantial cost of animal testing, the stringent regulatory framework for genetic engineering, and the lack of qualified professionals are expected to inhibit the market growth during the forecast period. 

Animal Genetics Market Segmentation

The global market for animal genetics market is segmented based on animal genetic products, services, and end-users. 

Based on animal genetic products, the global market for animal genetics market is segmented into genetic materials and live animals. The live animals are further divided into poultry, bovine, porcine, canine, and others. The genetic materials are sub-segmented into semen and embryo. 

Based on services, the global market for animal genetics is segmented into genetic disease tests, DNA typing, gene trait tests, and others. 

Based on end-user, the global market for animal genetics is segmented into veterinary hospitals & clinics, diagnostic centers, research centers and institutes, and others. 

Animal Genetics Market Regional Analysis

Regionally, the global animal genetics market is segmented into the Americas, Europe, Asia Pacific, and the Middle East and Africa.

The Americas dominated the global market for animal genetics in 2017. This was due to the growth in the North American region, primarily due to factors such as growing demand for animal products such as pork and mutton. Moreover, rapid urbanization is likely to spur market demand for live animals in the coming years. Growing adoption of artificial insemination, particularly in cattle, sheep, pigs, and goats, is fueling the market growth.

Europe was the second-largest region for the global animal genetics market. Due to rising awareness of animal health, the increase in the number of numerous animal genetic diseases, and the increased prevalence of the zoonotic disease is projected to provide this market with profitable growth opportunities.

The Asia Pacific was expected to be the fastest-growing area on the global market for animal genetics in 2017. Factors due to the increasing population of livestock and the development of DNA typing and genetic testing methods further increase the demand for genetic trait tests and various diagnostic tests. 

Animal Genetics Market Key players

Some of the major participants in the global animal genetics market are Neogen Corporation (US), Genus (UK), URUS (US), Groupe Grimaud (France), Animal Genetics (US), CRV Holding B.V. (The Netherland), Topigs Norsvin (Netherlands), Zoetis (US), EW Group (Germany), Envigo (US) Hendrix Genetics BV (The Netherland), Alta Genetics (US), vetGen (US), and others.

Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/animal-genetics-market-7004 

 

In-Vitro Diagnostics Market is Expected to Exhibit a Strong CAGR during forecast period upto 2023

 Market Highlights

As per the latest report published by Market Research Future (MRFR) the global market for in-vitro diagnostics will record a CAGR of 8.16% between 2018 and 2023. The market is expected to surpass a valuation of USD 102,500 Mn by the end of the assessment period. In-vitro diagnostics (IVD) combines the application of reagents, medical devices and accessories for performing complex test procedures on biological specimens such as tissue, blood and urine taken from human body. In-vitro diagnostics is increasingly used for diagnosis of medical conditions and detection of infection. IVD has emerged as an important medical technology for overcoming challenges faced in diagnosis and management of diseases. Such factors are supporting the growth of the global IVD market.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/1165

IVD is more precise than conventional test procedures and thereby gaining a quick popularity. In fact, many of the modern test procedures cannot be carried out without using IVD technology. Medical diagnostic device manufacturers are likely to capitalized on the market opportunity that has emerged. Demand for IVD services has grown substantially in recent years, which is attributable to the rising number of private diagnostics centers.   Moreover, advances in diagnostics technology coupled with the expanding global geriatric population, which is necessitating faster and more accurate diagnosis is likely to provide an impetus to the in-vitro diagnostics market in the forthcoming years. Other factors such as increased occurrence of chronic diseases and acceptance of molecular diagnostics in personalized medicines have also raised the importance of IVD.

Global In-Vitro Diagnostics Market: Segmental Analysis

MRFR’s report includes a through segmental analysis of the global in-vitro diagnostics market based on product & services, technology, application and end-user. Based on product & services, the market has been segmented into reagents & kits, instruments, and data management software. In 2017, the reagents and kits segment accounted for the largest market share. The segment is expected retain its top position over 2023, exhibiting a CAGR of 9.34%.  By technology, the market has been segmented into immunoassay/ immunochemistry, clinical chemistry, molecular diagnostics, microbiology and hematology. The clinical chemistry segment currently commands for more than one-third share of the market. This is primarily owing to the rapid integration of advanced technologies in clinical diagnostics. Meanwhile, the molecular diagnostics segment is projected to capture the highest during the assessment period. By application, the market has been segment into infectious diseases, and non-infectious diseases. In 2017, the infectious diseases segment accounted for over 60% of the market share. High prevalence of infectious disease is the primary driver of the segment’s growth. By end user, the market has been segmented into hospitals, laboratories and academic institutes. The hospitals segment holds the most dominant position – a majority of test are performed in hospitals. Hospitals continue to witness high patient influx despite the growing number of diagnostics centers.

Global In-Vitro Diagnostics Market: Regional Analysis

The in-vitro diagnostics market has been covered across North America, Europe, South America, the Middle East & Africa (MEA) and Asia Pacific (APAC). North America and South America collectively accounted for close to 40% share of the market in 2017. North America, in particular, is expected to remain highly lucrative market for in-vitro diagnostics. Easier accessibility along with high healthcare expenditure has a positive impact on the region’s market. The market in Asia-Pacific is likely to increase at a relatively higher CAGR over 2023.

Growth In-Vitro Diagnostics Market: Competitive Landscape

MRFR in its report has profiled some of prominent market players, which include Abbott Laboratories, Bio-Rad Laboratories Inc, Becton Dickinson and Company, Grifols S.A, Sysmex Corporation, Siemens AG, BioMérieux S.A, Ortho Clinical Diagnostics, Thermo Fisher Scientific, F. Hoffmann-La Roche AG, DiaSorin S.p.A, Danaher Corporation and Qiagen N.V

FOR MORE DETAILS  – https://www.marketresearchfuture.com/reports/in-vitro-diagnostics-market-1165